{"id":"W4396900273","doi":"10.1002/cac2.12547","title":"Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Apatinib; Medicine; Oncology; Cervical cancer; Internal medicine; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002630221,0.000358109,0.0006978635,0.0003284239,0.0003630326,0.001014035,0.0004110975,0.0007068177,0.000699112],"category_scores_gemma":[0.001840846,0.0001950077,0.0009173432,0.0004616219,0.0003106247,0.0007382452,0.0004733864,0.00142091,0.0001710767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008321504,"about_ca_system_score_gemma":0.0009506539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006612155,"about_ca_topic_score_gemma":0.001456073,"domain_scores_codex":[0.9993018,0.0002638847,0.00006157863,0.0001374461,0.0001304336,0.0001048158],"domain_scores_gemma":[0.9985197,0.000214637,0.0004978738,0.00009689379,0.000135644,0.0005351945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1489464,0.004419041,0.755917,0.0005061812,0.003195084,0.0006932672,0.0004084019,0.002552859,0.007076669,0.0001528124,0.004403282,0.07172907],"study_design_scores_gemma":[0.01963019,0.06869975,0.8980293,0.0001351176,0.00209261,0.001260906,0.000186903,0.002340507,0.00214506,0.0002130933,0.005201624,0.00006497969],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958133,0.002371565,0.0001160842,0.0001909273,0.00002176019,0.0001222915,0.0007622105,0.000005982507,0.0005957726],"genre_scores_gemma":[0.9968736,0.0004901386,0.0001231542,0.0001804779,0.00004400793,0.0001426272,0.001906418,0.00000317924,0.0002363136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002630221,"threshold_uncertainty_score":0.01391011,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03813081594581162,"score_gpt":0.3588766162722905,"score_spread":0.3207458003264789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}